
Oxford AstraZeneca vaccine effective against ‘Kent’ variant
A preprint of ongoing work to assess effectiveness of Oxford’s ChAdOx1 coronavirus vaccine shows that the existing vaccine has similar efficacy against the B.1.1.7 ‘Kent’ coronavirus strain currently circulating in the UK to previously circulating variants. The Oxford University researchers who developed the ChAdOx1-nCoV 19 vaccine have found that it… Read More















